[ET Net News Agency, 15 April 2024] CARDIOFLOW-B (02160) rose 7.5% to HK$1, breaking
above the 10-D SMA of HK$0.962.
It hits an intra-day high of HK$1.06, and an intra-day low of HK$0.9. The total shares
traded was 3.19 million, with a value of HK$3.02m. The active buy/sell ratio is 78:22,
with net buying turnover of HK$1.63m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$51,353, with volume weighted average price of HK$0.931.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$272,425,
with volume weighted average price of HK$0.931.
Basic Information
=================
--------------------------------
Nominal 1.000 % Chg +7.53%
High 1.060 Low 0.900
Shares Tr 3.19m Turnover 3.02m
10-D SMA 0.962 %H.V 65.298
20-D SMA 1.058 VWAP 0.947
50-D SMA 1.204 RSI14 41.339
--------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 78:22, with net buying
turnover of HK$1.63m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 1.00 +7.53
GENSCRIPT BIO (01548) 11.98 -6.11
INNOVENT BIO (01801) 35.85 -4.02
JXR (01951) 2.38 -1.65
EVEREST MED-B (01952) 24.40 -6.69
WUXI BIO (02269) 13.60 -2.16
WUXI APPTEC (02359) 34.15 -2.71
BEIGENE (06160) 83.65 -2.39
ZAI LAB (09688) 10.94 -5.20
AKESO (09926) 47.90 -3.23
---------------------------------------------
(ed)